tradingkey.logo

Medtronic PLC

MDT

89.340USD

-0.900-1.00%
종가 08/01, 16:00ET시세는 15분 지연됩니다
114.53B시가총액
24.57P/E TTM

Medtronic PLC

89.340

-0.900-1.00%
자세한 내용은 Medtronic PLC 회사
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
회사 정보
종목 코드 MDT
회사 이름Medtronic PLC
상장일Nov 21, 1977
설립일2014
CEOMr. Geoffrey S. (Geoff) Martha
직원 수95000
유형Ordinary Share
회계 연도 종료Nov 21
주소Building Two Parkmore Business Park West
도시DUBLIN
증권 거래소NYSE Consolidated
국가Ireland
우편 번호H91 4K49
전화1135314381700
웹사이트https://www.medtronic.com/
종목 코드 MDT
상장일Nov 21, 1977
설립일2014
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.06M
+3.66%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
496.43K
+2.01%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
120.89K
+8.81%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
48.79K
+25.09%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
47.95K
+4.05%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.16K
+4.88%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
39.45K
+28.29%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.52K
+9.50%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.06M
+3.66%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
496.43K
+2.01%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
120.89K
+8.81%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
48.79K
+25.09%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Other
9.18B
27.37%
지역별USD
이름
수익
비율
United States
17.17B
51.20%
Rest of World
16.25B
48.45%
Ireland
116.00M
0.35%
사업별
지역별
사업별USD
이름
수익
비율
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Other
9.18B
27.37%
주식 보유 통계
마지막 업데이트: Sat, Jul 26
마지막 업데이트: Sat, Jul 26
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.71%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.69%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.79%
주주
주주
비율
The Vanguard Group, Inc.
9.71%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.69%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.79%
주주 유형
주주
비율
Investment Advisor
45.69%
Investment Advisor/Hedge Fund
29.28%
Research Firm
3.90%
Pension Fund
2.28%
Bank and Trust
2.02%
Hedge Fund
1.92%
Sovereign Wealth Fund
1.24%
Insurance Company
0.38%
Individual Investor
0.25%
Other
13.05%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
3747
1.12B
87.05%
-12.52M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
2023Q1
3738
1.14B
85.40%
-14.71M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
124.44M
9.71%
+807.51K
+0.65%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
68.93M
5.38%
+886.72K
+1.30%
Mar 31, 2025
State Street Global Advisors (US)
60.04M
4.69%
-392.70K
-0.65%
Mar 31, 2025
Capital Research Global Investors
41.57M
3.24%
+8.36M
+25.19%
Mar 31, 2025
JP Morgan Asset Management
27.99M
2.18%
+3.65M
+15.02%
Mar 31, 2025
Geode Capital Management, L.L.C.
27.92M
2.18%
+860.11K
+3.18%
Mar 31, 2025
MFS Investment Management
20.60M
1.61%
+1.37M
+7.14%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.57M
1.14%
-1.01M
-6.49%
Dec 31, 2024
DWS Investment GmbH
14.36M
1.12%
-297.37K
-2.03%
Mar 31, 2025
BlackRock Financial Management, Inc.
14.15M
1.1%
+923.56K
+6.99%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sun, Jul 6
마지막 업데이트: Sun, Jul 6
이름
비율
Absolute Select Value ETF
5.31%
Polen Capital International Growth ETF
5.15%
Cullen Enhanced Equity Income ETF
4.57%
Madison Covered Call ETF
4.36%
iShares U.S. Medical Devices ETF
4.32%
USCF Dividend Income Fund
3.53%
First Trust Active Global Quality Income ETF
3.13%
NYLI Healthy Hearts ETF
3.07%
American Century Focused Large Cap Value ETF
3.03%
iShares Health Innovation Active ETF
2.86%
더 보기
Absolute Select Value ETF
비율5.31%
Polen Capital International Growth ETF
비율5.15%
Cullen Enhanced Equity Income ETF
비율4.57%
Madison Covered Call ETF
비율4.36%
iShares U.S. Medical Devices ETF
비율4.32%
USCF Dividend Income Fund
비율3.53%
First Trust Active Global Quality Income ETF
비율3.13%
NYLI Healthy Hearts ETF
비율3.07%
American Century Focused Large Cap Value ETF
비율3.03%
iShares Health Innovation Active ETF
비율2.86%
주식 배당금
지난 5년 동안 총 17.37B USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
tradingkey.logo
tradingkey.logo
당일 거래 데이터는 Refinitiv에서 제공하며, 이용 약관이 적용됩니다. 역사적 및 현재 종가 데이터는 Refinitiv에서 제공합니다. 모든 시세는 현지 거래소 시간 기준입니다. 미국 주식 시세의 실시간 마지막 거래 데이터는 Nasdaq을 통해 보고된 거래만 반영됩니다. 당일 거래 데이터는 최소 15분 지연되거나 거래소 요구 사항에 따라 다를 수 있습니다.
* 참고자료, 분석 및 트레이딩 전략은 제3자 제공업체인 Trading Central에서 제공하며, 분석가의 독립적인 평가와 판단에 기반한 시각으로, 투자자의 투자 목표와 재정 상황은 고려되지 않습니다.
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유
KeyAI